Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Puerto Rico

2 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Where

  San Juan, Yauco

  Életkor

  18 év and over

  People

  1046 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06717347 · EU 2024-515566-13-00
• 2. fázisTaking people
  Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

  Where

  San Juan

  Életkor

  65 év to 99 év

  People

  80 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT05952024